Data / Drug companies / Unichem Pharmaceuticals (USA), Inc.
Unichem Pharmaceuticals (USA), Inc.: 36 products in the FDA NDC directory, labeler code 76385
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Unichem Pharmaceuticals (USA), Inc. (labeler code 76385) lists 36 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 35 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 25, 2026.
The request: Watch Unichem Pharmaceuticals (USA), Inc. (FDA labeler code 76385): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76385
- Products in commercial distribution
- 36
- Packages
- 68
- Finished drugs by generic name
- 17
- Prescription products
- 35
- Over the counter products
- 1
- Controlled substance products
- Schedule V 1
- Flagged as original packager
- 36 of 36 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- October 1, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 36 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 35 | 97.2% |
| Over the counter drugs | 1 | 2.8% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Carvedilol | 4 | 35 |
| Flecainide acetate | 3 | 13 |
| Sotalol hydrochloride | 3 | 25 |
| Metolazone | 3 | 22 |
| Nadolol | 3 | 17 |
| Pioglitazone hydrochloride | 3 | 8 |
| Methscopolamine bromide | 2 | 5 |
| Etodolac | 2 | 31 |
| Metformin hydrochloride | 2 | 79 |
| Sotalol hydrochloride tables af | 2 | 1 |
| Methocarbamol | 2 | 67 |
| Pindolol | 2 | 9 |
| Cyproheptadine hydrochloride | 1 | 24 |
| Primaquine phosphate | 1 | 5 |
| Sotalol hydrochloride tablets af | 1 | 1 |
| Diphenoxylate hydrochloride and atropine sulfate | 1 | 22 |
| Ketotifen fumarate | 1 | 19 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 25 | 69.4% |
| Tablet, film coated | 8 | 22.2% |
| Tablet, extended release | 2 | 5.6% |
| Solution | 1 | 2.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pioglitazone hydrochloride | 76385-180 | Tablet | Generic drugs (ANDA) | June 25, 2026 |
| Pioglitazone hydrochloride | 76385-179 | Tablet | Generic drugs (ANDA) | June 25, 2026 |
| Pioglitazone hydrochloride | 76385-178 | Tablet | Generic drugs (ANDA) | June 25, 2026 |
| Flecainide Acetate | 76385-147 | Tablet | Generic drugs (ANDA) | January 11, 2024 |
| Flecainide Acetate | 76385-146 | Tablet | Generic drugs (ANDA) | January 11, 2024 |
| Flecainide Acetate | 76385-145 | Tablet | Generic drugs (ANDA) | January 11, 2024 |
| Ketotifen fumarate | 76385-106 | Solution | Generic drugs (ANDA) | October 15, 2021 |
| Etodolac | 76385-119 | Tablet, film coated | Generic drugs (ANDA) | August 1, 2021 |
| Etodolac | 76385-118 | Tablet, film coated | Generic drugs (ANDA) | August 1, 2021 |
| Metolazone | 76385-138 | Tablet | Generic drugs (ANDA) | March 30, 2021 |
| Metolazone | 76385-137 | Tablet | Generic drugs (ANDA) | March 30, 2021 |
| Metolazone | 76385-136 | Tablet | Generic drugs (ANDA) | March 30, 2021 |
| Cyproheptadine Hydrochloride | 76385-130 | Tablet | Generic drugs (ANDA) | March 1, 2020 |
| Sotalol Hydrochloride AF | 76385-127 | Tablet | Generic drugs (ANDA) | February 21, 2020 |
| Sotalol Hydrochloride AF | 76385-126 | Tablet | Generic drugs (ANDA) | February 21, 2020 |
| Sotalol Hydrochloride AF | 76385-125 | Tablet | Generic drugs (ANDA) | February 21, 2020 |
| Pindolol | 76385-132 | Tablet | Generic drugs (ANDA) | February 1, 2020 |
| Pindolol | 76385-131 | Tablet | Generic drugs (ANDA) | February 1, 2020 |
| Nadolol | 76385-135 | Tablet | Generic drugs (ANDA) | July 26, 2019 |
| Nadolol | 76385-134 | Tablet | Generic drugs (ANDA) | July 26, 2019 |
| Nadolol | 76385-133 | Tablet | Generic drugs (ANDA) | July 26, 2019 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | 76385-107 | Tablet | Generic drugs (ANDA) | May 15, 2019 |
| Metformin hydrochloride | 76385-128 | Tablet, extended release | Generic drugs (ANDA) | July 17, 2018 |
| Metformin hydrochloride ER | 76385-129 | Tablet, extended release | Generic drugs (ANDA) | June 28, 2018 |
| Methocarbamol | 76385-124 | Tablet, film coated | Generic drugs (ANDA) | January 15, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.